ACAD
27.49
-0.52
-1.86%
AEMD
2.05
-0.01
-0.49%
APRI
1.01
-0.03
-2.88%
ARNA
1.36
+0.02
+1.49%
ATEC
2
-0.09
-4.31%
CNAT
5.3
0.00
0.00%
CRXM
0.17
+0.05
+40.50%
CYTX
1.08
+0.12
+12.50%
DXCM
67.58
-1.27
-1.84%
GNMK
13.09
-0.12
-0.91%
HALO
12.74
-0.05
-0.39%
ILMN
174.72
-0.2
-0.11%
INNV
0.107
-0.001
-0.7442%
INO
7.12
+0.03
+0.42%
ISCO
1.5
-0.14
-8.54%
ISIS
57.56
0.00
0.00%
LGND
113.74
+0.3
+0.26%
LPTN
2.93
0.00
0.00%
MBVX
1.67
-0.04
-2.34%
MEIP
1.65
+0.01
+0.61%
MNOV
5.76
+0.11
+1.95%
MRTX
3.4
-0.25
-6.85%
MSTX
0.131
0.00
0.00%
NBIX
53.53
-0.11
-0.21%
NUVA
71.92
+0.38
+0.53%
ONCS
0.92
+0.02
+2.22%
ONVO
2.83
+0.02
+0.71%
OREX
2.95
-0.08
-2.64%
OTIC
13.4
+0.15
+1.13%
QDEL
24.61
+0.04
+0.16%
RCPT
231.96
0.00
0.00%
RGLS
1.425
+0.05
+3.636%
RMD
69.584
+0.074
+0.1063%
SCIE
0.001
+0.00
+20.0000%
SPHS
2.42
-0.06
-2.42%
SRNE
1.575
-0.15
-8.696%
TROV
0.736
-0.04
-5.1804%
VICL
2.3
+0.01
+0.44%
VOLC
18
0.00
0.00%
ZGNX
12.75
-0.35
-2.67%
ACAD
27.49
-0.52
-1.86%
AEMD
2.05
-0.01
-0.49%
APRI
1.01
-0.03
-2.88%
ARNA
1.36
+0.02
+1.49%
ATEC
2
-0.09
-4.31%
CNAT
5.3
0.00
0.00%
CRXM
0.17
+0.05
+40.50%
CYTX
1.08
+0.12
+12.50%
DXCM
67.58
-1.27
-1.84%
GNMK
13.09
-0.12
-0.91%
HALO
12.74
-0.05
-0.39%
ILMN
174.72
-0.2
-0.11%
INNV
0.107
-0.001
-0.7442%
INO
7.12
+0.03
+0.42%
ISCO
1.5
-0.14
-8.54%
ISIS
57.56
0.00
0.00%
LGND
113.74
+0.3
+0.26%
LPTN
2.93
0.00
0.00%
MBVX
1.67
-0.04
-2.34%
MEIP
1.65
+0.01
+0.61%
MNOV
5.76
+0.11
+1.95%
MRTX
3.4
-0.25
-6.85%
MSTX
0.131
0.00
0.00%
NBIX
53.53
-0.11
-0.21%
NUVA
71.92
+0.38
+0.53%
ONCS
0.92
+0.02
+2.22%
ONVO
2.83
+0.02
+0.71%
OREX
2.95
-0.08
-2.64%
OTIC
13.4
+0.15
+1.13%
QDEL
24.61
+0.04
+0.16%
RCPT
231.96
0.00
0.00%
RGLS
1.425
+0.05
+3.636%
RMD
69.584
+0.074
+0.1063%
SCIE
0.001
+0.00
+20.0000%
SPHS
2.42
-0.06
-2.42%
SRNE
1.575
-0.15
-8.696%
TROV
0.736
-0.04
-5.1804%
VICL
2.3
+0.01
+0.44%
VOLC
18
0.00
0.00%
ZGNX
12.75
-0.35
-2.67%
Home » Archive by Category

Drug Discovery

San Diego’s Antibody-Drug Conjugate Research Highlighted at #WorldADC Meeting in October

November 24, 2014 – 8:11 am
WorldADC

San Diego was host to the World Antibody Drug Conjugate (ADC) Meeting and Awards October 26-29th 2014. ADCs are an exciting new class of oncology therapeutics utilizing monoclonal antibodies conjugated to cytotoxic drugs, resulting in …

SDBN August 21st 2012 Event At The Sanford Consortium For Regenerative Medicine

August 3, 2012 – 12:41 pm

The Sanford Consortium for Regenerative Medicine is a stem cell research facility representing a collaboration between five of San Diego’s finest research institutions: Sanford-Burnham Medical Research Institute, The Salk Institute, The Scripps Research Institute and …

SDBN June 25th Event With Lilly: Open Innovation Drug Discovery

June 4, 2012 – 1:48 am

San Diego biotech has grown thanks to a collaborative spirit which is sometimes manifested in the acquisition and joining of companies towards a common goal. Lilly’s presence here is indicative of this type of growth, …

San Diego’s Biotechnology Companies: Who’s Taking Off?

March 8, 2012 – 9:13 am

Here at SDBN we’ve been updating our directory of 400+ San Diego biotech companies.  We were surprised to find close to 40 companies removed from the local scene – due to acquisition or shut down.  …

SDBN March 26th 2012 Event with Organovo

March 6, 2012 – 1:59 pm

Organovo is an exciting San Diego biotech company with technology to create human tissue through a technique called 3D bioprinting. The tissue can be used for drug discovery and development, and the company has been …

Focus on San Diego: Life Science Conferences Spring 2012

January 31, 2012 – 11:56 am

This spring San Diego downtown will be buzzing with scientific discussions as our city hosts a number of major scientific symposia.  We are excited to attend and soak in all the science that will be …

Virtual Biotech Part 1: What We Learned About Effectively Outsourcing a Drug Discovery Program

July 28, 2011 – 12:04 pm

The first in our Virtual Biotech series, our July 19th event was a success.  Thanks to our participants – some of San Diego’s leading virtual drug discovery scientists and CROs – for sharing their valuable …

SDBN July 19th Event: Virtual Biotech Part 1: How to Effectively Outsource a Drug Discovery Program

July 1, 2011 – 3:47 pm

Changes in the drug discovery landscape have presented many tough challenges for our region, including downsizing for larger companies and a dearth of VC funding for startups. With these challenges come opportunities, however, because drug …

SDBN June 21st Event Featuring aTyr Pharma

May 27, 2011 – 9:58 am

The San Diego Biotechnology Network’s June 21st event will feature aTyr Pharma, with Board Member and CEO Jeffry Watkins (Bio) giving a talk titled “Innovation: Where is our Biology?” aTyr is developing therapeutics based on …

SDBN April 19th 2011 Event Featuring Celgene

March 22, 2011 – 6:15 pm

Through research, acquisitions, and mergers, Celgene has built a robust product portfolio and pipeline in hematology and oncology. This accomplishment is quite a feat in today’s environment, with pharma pipelines dwindling, and they are one …